The other concept, pursued by Pfizer, Japan's Ono Pharmaceutical, the AstraZeneca-Renovis partnership and numerous other firms, is to find a brain-cell protector that could be used to stabilize nerve cells and prevent further damage.

FORBES: Brain Repair